Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 011552
Company: GLAXOSMITHKLINE

Products on NDA 11552

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	TABLET;ORAL	Discontinued	None	Yes	No
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	TABLET;ORAL	Discontinued	None	Yes	No
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	TABLET;ORAL	Discontinued	None	Yes	No
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	TABLET;ORAL	Discontinued	None	Yes	No
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	INJECTABLE;INJECTION	Discontinued	None	Yes	No
STELAZINE	TRIFLUOPERAZINE HYDROCHLORIDE	EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**	CONCENTRATE;ORAL	Discontinued	None	Yes	No